XBKK
RPH
Market cap78mUSD
Nov 12, Last price
4.92THB
Name
Ratchaphruek Hospital PCL
Chart & Performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Ratchaphruek Hospital Public Company Limited, known as Ratchaphruek Hospital, runs a healthcare facility in Thailand, delivering a comprehensive array of medical services. Its extensive offerings encompass various specialties, including internal medicine (such as dermatology, neurology, hematology, pulmonology, rheumatology, gastroenterology, nephrology, diabetes and endocrine care, and cardiology), a range of surgical procedures (general, urological, and colorectal), and specialized treatments in areas like pediatrics, orthopedics, ear-nose-throat (ENT), ophthalmology, obstetrics and gynecology, preventative health check-ups, dentistry, anesthesiology, emergency care, stroke management, breast health, hearing and balance, rehabilitation, and diagnostic radiology. The hospital also supplies medicines and medical provisions. Incorporated in 1993 in Khon Kaen, Thailand, the company was initially named Sithan Karnpat Company Limited, changing to its current designation in September 2016.
Valuation
Title THB in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||